News tagged with: hepatology
-
Could weight loss drug benefit patients living with alcohol addiction, liver disease and obesity?
University of Plymouth news: Our researchers are leading a new study testing if a weight loss drug already being used to treat obesity and diabetes could also benefit patients impacted by alcoholism and obesity, two of the biggest causes of liver disease
-
Scientists explore whether plastic particles could be linked to significant rises in liver disease
University of Plymouth news: A new article written by experts from Plymouth’s Centre of Environmental Hepatology explores whether tiny plastic particles are directly contributing to the soaring global rates of liver disease.
-
Study explores whether dietary supplement could provide first effective treatment for cirrhosis
University of Plymouth news: The University is leading the BOOST trial, which will assess whether the HMB supplement can benefit some of the 60,000 people living with the liver condition in the UK
-
Research aims to identify why some people become severely ill as a result of COVID-19
A joint study between the University and University Hospitals Plymouth NHS Trust (UHP) is analysing the differing immune responses of COVID-19 patients and working to develop a simple test that could help predict who is likely to develop serious illness.